The Access to Medicine Foundation's Strategic Direction 2022-2026
14 December 2021
Over the next five years, the Foundation will seek to mobilise the big players among the generic medicine manufacturers, vaccine manufacturers, diagnostics companies and medical gas companies – as well as continuing to drive change in Big Pharma.
The Strategic Direction includes quick-reads on each of these five essential healthcare sectors, outlining the specific challenges that need to be tackled, and how the Access to Medicine Foundation plans to motivate the pivotal players to move in the right direction.
This short publication provides a guide to how our ‘model for change’ works in practice, laying out how the Foundation's tried-and-tested model has worked so far – and how we plan to leverage it to the fullest extent as we go forward.
Download the PDF to find out more, and to read what the experts say about the Access to Medicine Foundation and our work – with endorsements from leading figures such as Bill Gates, Mary Robinson, Dr Githinji Gitahi, Sir Andrew Witty, Dame Sally Davies, and Leith Greenslade.